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Balloon angioplasty and stenting have been
widely used to treat patients with coronary and
peripheral arterial occlusive disease.1,2 Despite the
relative safety of the procedure, complications of
balloon angioplasty and stenting, including embol-
ic events, have been reported to occur at all
anatomic sites.2,3 The use of balloon angioplasty
and stenting in the management of stenosis at the
carotid bifurcation has been limited, primarily
because of the availability of excellent surgical
therapy and because of concern about embolic
stroke.4
The morphologic characteristics of plaques at the
carotid bifurcation have been extensively studied.
The complex histopathologic features of these lesions
also have been well described,5-7 which has ham-
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pered the development of animal models that can be
used to evaluate embolic events after endovascular
intervention. 
We developed an ex vivo human carotid stenting
model to quantitatively analyze the risk for embolic
events associated with balloon angioplasty and stent-
ing.8,9 This model was used to correlate embolic risk
with lesion characteristics in the hope that this
model would aid in the selection of appropriate
lesions for management with this technique. 
METHODS
Elasticity of human carotid artery adventitia.
To find a material that has mechanical properties sim-
ilar to those of human carotid artery adventitia, a
study of elasticity was performed on different materi-
als, including human carotid artery adventitia (n = 3),
canine carotid artery adventitia (n = 3), expanded
polytetrafluoroethylene (ePTFE) graft (n = 3) (7 mm
ePTFE graft; W. L. Gore and Associates, Flagstaff,
Ariz.), and ePTFE graft with the outer reinforcing
wrap removed (n = 3). Carotid arteries were obtained
from patients whose bodies were examined by means
of postmortem studies. None of these specimens had
marked carotid atherosclerotic disease. Each of the
materials was cut to 4 cm in length and dilated with a
balloon (Ultra-thin; Medi-tech, Watertown, Mass.)
that was 50% larger in diameter than the diameter of
the tested material at rest. The balloon was inflated
and the outer diameter of the material was measured
under a dissecting microscope (magnification, 3· ) at
every 0.5 atm increase in inflating pressure (Fig. 1).
The elasticity of a given material can be described
according to the modulus of elasticity, which is an
innate property of the material that determines how
strain responds to stress.10 We calculated the modulus
of each material using the following equation:
Modulus (of elasticity) = Stress ÷ Strain = P ÷ (D d/d),
where P is the pressure exerted on the arterial wall, D d
is the change in diameter measured in the blood ves-
sel, and d is the original diameter of the blood vessel. 
The stress of a vessel is reflected in the pressure
on the artery. Strain is obtained by dividing the
change in diameter size by the original arterial diam-
eter. Within its elastic limit, an artery exhibits a linear
relation between stress and strain. In our experiment,
stress and strain were determined as the averages of
three tests from three individual blood vessels or
materials (Fig. 1). Fig. 1 shows that stress and strain
follow a relatively linear relation when pressure is less
than 3 atm. Accordingly, the modulus of elasticity
was calculated for each of the materials at 3 atm by
means of the foregoing equation. The moduli for
canine, human, ePTFE graft, and ePTFE graft with
outer reinforcing wrap removed were 4.6, 8.6, 15.0,
and 30.3. Therefore we used ePTFE with the outer
reinforcing wrap removed, which most closely mim-
icked the physical property of human carotid artery
adventitia, for re-creation of the adventitia.
Preparation of the carotid specimen. Human
carotid plaque specimens (n = 24) were obtained
from patients undergoing standard carotid
endarterectomy procedures for clinically significant
stenosis of the carotid bifurcation. The surgical
technique used for carotid endarterectomy is
described in detail elsewhere.11 Endarterectomy
specimens were removed as casts of the carotid
bifurcation vessels devoid only of the adventitia and
were kept circumferentially intact (Fig. 2A). The
excised specimens were encased in an ePTFE wrap
(6, 7, or 8 mm thin wall ePTFE; W. L. Gore and
Associates) in an effort to re-create a structural
adventitia (Fig. 2B). The outer reinforcing wrap of
the encasing ePTFE graft was removed and
stretched with surgical clamps to approximate the
size of the outer diameter of the plaque. The distal
half of each ePTFE covering was cut open longitu-
dinally, and the plaque specimen was inserted into
the lumen of the graft. The size discrepancy
between the internal carotid and the common
carotid arteries was managed by means of trimming
and suturing the redundant ePTFE with CV-7
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Fig. 1. Elasticity of human carotid artery adventitia. Data
are expressed as mean of triplicate studies. Ca-CCA,
canine common carotid artery; Hu-CCA, human com-
mon carotid artery; PTFE W(-), ePTFE graft without
outer reinforcing wrap; PTFE W(+), ePTFE grafting with
outer reinforcing wrap.
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Fig. 3. A, Distal view retrograde into the internal carotid artery. There is no constriction of
the plaque by the wrap or any space between the plaque and the ePTFE covering. Mural
thrombus is seen at the distal end of the stenosis (arrow). B, Distal view of the same internal
carotid plaque specimen after balloon angioplasty and stenting (Palmaz stent).
FPO
Fig. 2. A, Specimen of human carotid plaque. Specimens are removed as casts of the carotid
bifurcation and were kept circumferentially intact. i, Internal carotid artery; e, external carotid
artery; c, common carotid artery; s, superior thyroid artery. B, Expanded PTFE wrapped spec-
imen. The distal half of the ePTFE graft is cut longitudinally, and the plaque is inserted into
the graft. Redundant ePTFE material covering the internal carotid plaque portion is trimmed






sutures (Gore-tex; W. L. Gore and Associates) (Fig.
2B). Care was taken to precisely match the size of
the ePTFE wrapping to prevent artificial constric-
tion of the plaque (Fig. 3A).
Specimens covered with ePTFE were connected
to a sheath equipped with a latex balloon at the tip
to secure the specimen for subsequent studies (Fig.
4). This specimen and sheath complex was then con-
nected to the inside of a radiolucent plastic bath
(Fig. 4). A bag containing isotonic saline solution
was positioned 130 cm above the bath and connect-
ed to the flush channel of the main port so that con-
tinuous saline flow could be maintained through the
lumen of the specimen during the entire endovascu-
lar procedure. A sheath connected to a three-way
valve was inserted into the center channel for
endovascular interventions and imaging.
Balloon angioplasty and stenting. Ex vivo
angiography of each carotid specimen was performed
by means of injection of contrast material into the
plaque through the flush valve of the main chamber
and imaging with a C-arm fluoroscope (OEC
Diasonics Model 9000; OEC Medical Systems, Salt
Lake City, Utah) (Fig. 5A). A radiopaque ruler was
placed beside the specimens to allow accurate angio-
graphic measurement. Recanalization of the specimen
was performed with an 0.018 inch steerable guide
wire (Hi-Torque Flex-T; Peripheral Systems Group,
Temecula, Calif.) with roadmap guidance. Lesions
with stenosis greater than 80% were predilated with a
5 mm · 2 cm angioplasty balloon (Ultra-thin
Diamond; Medi-tech) or a 3 mm · 2 cm coronary
balloon (Scimed, Maple Grove, Minn.) before stent-
ing. Balloon dilation was performed up to a pressure
of 7 atm for 30 seconds. Angiograms were obtained
after each balloon dilation (Fig. 5B). Carotid plaque
specimens received either Palmaz balloon-expandable
stents (P104, P154, P204, P294; Cordis, Warren,
N.J.) or self-expanding Wallstent endoprostheses (8
mm · 5 cm; Schneider, Minneapolis, Minn.). After
stent deployment, completion angiography and
intravascular ultrasound examination were performed
to confirm adequate stent deployment (Fig. 5C).
Incomplete stent deployment was managed with
additional balloon dilation.
Collection and analysis of embolic particles.
A continuous flow of saline solution was maintained
through the specimen throughout all endovascular
procedures. The effluent was collected and filtered
(120 m m) at the conclusion of the intervention. The
number, size, and composition of recovered embol-
ic particles were analyzed with a dissecting micro-
scope at magnification 70· (SMZ-U; Nikon, Tokyo,
Japan) and in paraffin-embedded histologic sections.
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Fig. 5. A, Ex vivo angiogram before intervention
(roadmap image), which reveals ulcerated plaque with
high-grade stenosis in the internal carotid artery. External
carotid artery is temporarily occluded with a clip (c) to
prevent preferential flow through this vessel. Superior thy-
roid artery is visualized (s). B, Angiogram after balloon
angioplasty. Increased luminal diameter is minimal after
initial balloon angioplasty. c, Calcification on lateral aspect
of the plaque; g, guide wire. C, Angiogram after stenting.
A wide lumen is restored after insertion of a Palmaz stent
(P-204) (s). r, Radiopaque ruler.
Fig. 4. Schematic of ex vivo apparatus and bath. The
ePTFE-covered plaque (CP) is connected to a custom-
made sheath by means of inflation of the latex balloon (B).
This plaque-sheath complex is connected to the main port
of the bath. A saline bag raised to 130 cm above the bath
is connected to the flush channel of the main port to
maintain continuous flow through the lumen of the spec-
imen (arrows). A sheath with a three-way valve at the
proximal end is inserted into the center channel of the
main port. This allows insertion of various endovascular
imaging and interventional devices. The effluent is
drained through a filter to collect the embolic particles
(EP) generated during the endovascular procedure.
Characterization of carotid specimens. For
the purpose of multivariate analysis, carotid speci-
mens were prospectively characterized according to
the presence of clinical symptoms before endarterec-
tomy and specific findings on angiographic images
and duplex ultrasonographic scans (Table I). These
characteristics have been shown to play a role in the
natural history of carotid disease and to correlate
with the outcome of carotid endarterectomy.7,12-17
Percentage stenosis was calculated with the fol-
lowing formula: Stenosis = {1 – [(MLD – OD) ÷
OD]} · 100, where MLD is the minimal luminal
diameter measured on the ex vivo angiogram before
intervention and OD is the outer diameter of the
internal carotid plaque. 
The presence or absence of plaque ulceration and
calcification was determined by means of evaluation
of angiograms and plain fluoroscopic images. The
presence of plaque echogenicity was determined at
preoperative duplex studies obtained with a high-
resolution 7.5 MHz linear scanner transducer. All
scans were recorded and subsequently characterized
according to the degree of echolucency seen with B-
mode scanning. The echo pattern of the plaque-free
arterial wall in question was used as a standard
because echogenicity may vary from patient to
patient. Plaques with an echolucent area ‡ 50% of the
total plaque area were characterized as echolucent
plaque (types 1 and 2 according to Geroulakos et
al.18 and Sterpetti et al.19), and those with an
echolucent area <50 % of the plaque area were char-
acterized as echogenic plaque (types 3, 4, or 5).
Statistical analysis. Continuous variables were
described as median and range. Wilcoxon rank sum
tests were used to assess univariate associations
between total number of particles generated and
dichotomous variables (lesion characteristics, Table
I). Variables for which analyses resulted in p values
smaller than 0.2 were incorporated into a multiple
regression analysis (SAS for Windows 6.11; SAS,
Cary, N.C.). Because the total number of particles
generated was not normally distributed, a logarithmic
transformation was applied in an attempt to make the
distribution approach normality and to meet the
assumptions of the analysis. Variables were considered
significant if the p value was less than 0.05.
RESULTS
Characteristics of plaques. Mean percentage
stenosis and diameter of the internal carotid artery
were 88% ± 10.7% and 7.5 mm ± 1.9 mm, respec-
tively, (mean value ± SD). Preoperative symptoms,
calcification, and ulceration were present in 46%, 42%,
and 33%, respectively, of the plaques. Sixty-three per-
cent of the plaques were obtained from men, and 56%
were characterized as echogenic plaques.
Technical success and number of particles.
Balloon angioplasty and stenting were successfully
performed on all but one specimen, in which the
plaque and wrapping ruptured after balloon angio-
plasty and stenting. This plaque contained noncom-
pressible circumferential calcification and did not
respond to balloon angioplasty. A good angiograph-
ic result (absence of vessel rupture, dissection, and
restoration of lumen demonstrated at angiography
and intravascular ultrasonography) was obtained for
the remaining 23 specimens (Figs. 3B and 5C). The
overall technical success rate for balloon angioplasty
and stenting was 96% (23 of 24 specimens).
Embolic particles were obtained in each instance,
and the number substantially varied among specimens
(median 15, range 2 to 126). These particles were
predominantly composed of atherosclerotic debris
and some organized thrombus and calcified material
(Fig. 6). The mean size of the particles was 338 ± 344
mm (mean value ± SD) and the range was 120 to
2100 m m. The total number of particles generated
from each specimen had a close positive correlation
with the maximum size of the particles (r = 0.45).
Univariate analysis of lesion characteristics.
Presence of preoperative symptoms, plaque ulcera-
tion or calcification, sex, and diameter of the vessel
did not significantly correlate with the number of
embolic particles recovered (Table I).
Echolucent plaques produced a significantly
higher number of embolic particles (26, range 3 to
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Table I. Univariate and multivariate analyses of variables 
Diameter of internal
Type of analysis Percentage stenosis Preoperative symptom Sex carotid artery Calcification Ulcer Echogenicity
Univariate 0.043 0.78 0.811 0.917 0.66 0.54 0.012
Multivariate 0.048 NP NP NP NP NP 0.023
Values are p values.
NP, Not performed.
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Fig. 6. Macroscopic view of embolic particles generated after angioplasty and stenting. These
particles consisted of atherosclerotic debris and calcified material (c) (filter size 120 m m; orig-
inal magnification 40· ).
FPO
Fig. 7. Quantitative analysis of embolic particles and correlation with variables. A, Echolucent
plaques generated a significantly higher number of embolic particles (median 26, range 3 to
126) as opposed to echogenic plaques (median 9.5, range 2 to 73, p = 0.012). B, Degree of
stenosis correlated with number of particles produced at balloon angioplasty and stenting (r =
0.55).
126) compared with echogenic specimens (9, range
2 to 73, p = 0.012) (Table I, Fig. 7A). In addition,
the degree of stenosis correlated with the generation
of embolic particles (r = 0.55, Fig. 7B). Plaques with
stenosis ‡ 90% generated a significantly higher num-
ber of particles (17.5, range 6 to 80) compared with
those with <90% stenosis (6.5, range 2 to 126, p =
0.043; Table I).
Multivariate analysis of lesion characteristics.
Multiple regression analysis revealed that echogenic-
ity (p = 0.023) and severity of stenosis (p = 0.048)
were significant independent risk factors (Table I).
DISCUSSION
The purpose of carotid endarterectomy and bal-
loon angioplasty and stenting is prevention of stroke
in the treatment of patients with carotid stenosis.
Any potential benefits of carotid endarterectomy
and balloon angioplasty and stenting in long-term
stroke prevention will be offset by high perioperative
or periinterventional stroke rates. Because the
method by which balloon angioplasty and stenting
manage carotid plaque is quite different from that of
carotid endarterectomy, we hypothesized that there
may exist a unique group of patients who might
have a higher periinterventional stroke rate and
therefore may not be suitable for this technique.
There are several causes of perioperative stroke after
carotid endarterectomy, including intraoperative
embolic events, acute thrombosis of the carotid
artery, and insufficient blood supply during arterial
clamping.19-21 Of these, embolic events are believed
to be the most important cause of stroke after bal-
loon angioplasty with or without stenting.4,22-24 Gil-
Peralta et al.22 performed balloon angioplasty on 82
patients with internal carotid stenosis and reported a
perioperative major stroke rate of 5%. Half these
strokes were believed to be caused by multiple
embolic occlusions of the middle cerebral artery.22
This investigation was designed to develop an ex
vivo human carotid model to analyze events that
may predispose balloon angioplasty and stenting to
the devastating complication of embolic stroke. The
study demonstrated that a significantly higher num-
ber of potential embolic particles were generated
from plaques that were echolucent on duplex ultra-
sound scans. B-mode ultrasonographic scans have
been shown to help differentiate gray-level intensi-
ties between simple fibrous plaque and those with
increased necrotic material.25 It also has been shown
that echogenicity is an important aspect of a plaque
and is associated with the presence of symptoms.18
Sterpetti et al.19 conducted follow-up studies with
patients with plaques of variable morphologic fea-
tures at duplex examination and found that echolu-
cent plaques (heterogeneous) demonstrated a signif-
icantly higher rate of new neurologic events than
echogenic plaques. The investigators concluded that
plaques with echolucent areas indicate intraplaque
hemorrhage and are therefore inherently less stable
and prone to fragmentation and embolization than
echogenic plaques. Histologic studies have con-
firmed that these echolucent plaques are predomi-
nantly composed of atheromatous debris, lipids, and
intraplaque hemorrhage, whereas echogenic plaques
mainly consist of more stable fibrous tissue.19,25-27
In view of the results of these studies, it is not sur-
prising that in our study echolucent plaques pro-
duced more particles than fibrous, echogenic
plaques after balloon angioplasty and stenting.
This study also showed that the severity of steno-
sis correlated with the number of embolic particles
recovered after balloon angioplasty and stenting.
Balloon angioplasty and stenting involve radial com-
pression and fracture of plaque to increase luminal
diameter. Higher compression pressures are re-
quired to displace plaque within lesions with greater
stenoses. It can be expected that a high compression
pressure applied to severely stenosed plaque con-
tributed to an increased incidence of embolic parti-
cles in our model. Holdsworth et al.28 reported that
the severity of stenosis and echolucency of carotid
plaques correlated and that these two variables were
dependent factors. Our study did not confirm this,
and these two factors appeared to be independent
variables for risk for particle embolization.
The clinical significance of the number of embol-
ic particles generated after balloon angioplasty and
stenting is not clear. Intuition leads one to believe
that patients among whom balloon angioplasty and
stenting produced a higher number of particles
would be expected to have a higher periinterven-
tional stroke rate than patients among whom fewer
particles are produced. Using transcranial Doppler
ultrasound, Ackerstaff et al.20 and Jansen et al.21
studied the effect of the total number of particles
detected during carotid endarterectomy on periop-
erative neurologic events. In these studies, it was
shown that the number of embolic particles detect-
ed with transcranial Doppler ultrasound during stan-
dard carotid endarterectomy correlated with the rate
of subsequent neurologic events.20,21 Although
transcranial Doppler evaluation did not allow accu-
rate identification of particle size, these studies clear-
ly showed the importance of the number of embol-
ic particles in the occurrence of perioperative stroke.
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That the number of particles generated closely cor-
related with the maximum size of the particles in our
study further supports the importance of the total
number of embolic particles in the occurrence of
perioperative stroke.
Balloon angioplasty and stenting are being inves-
tigated in several clinical trials, and the feasibility of
this technique has been substantiated.29-33 However,
the true safety and long-term efficacy of this proce-
dure have to be better defined. These studies have
shown a perioperative stroke or death rate of 5.3% to
8.2%.29-33 The percentage of patients without symp-
toms included in these trials ranged from 13% to 72%.
Because the perioperative complication rate is highly
dependent on the operative indication and patient
population being treated, it is difficult to compare
these morbidity rates with previously published
results of carotid endarterectomy.12-16 Nevertheless,
these initial trials have been criticized because of the
high rate of neurologic complications.23,34 These ini-
tial trials had various exclusion criteria, including the
presence of calcification, ulceration, and mural
thrombus, in an attempt to reduce periinterventional
neurologic events.29-33 Unfortunately, our study
showed that none of these factors was a significant
risk factor for the generation of embolic particles.
Moreover, none of these trials excluded patients with
echolucent plaques and plaques with a degree of
stenosis greater than 90%, both of which we demon-
strated as being independent risk factors for the gen-
eration of embolic particles. We believe that if patients
with such characteristics are excluded from clinical tri-
als, it may be possible to further minimize the risk for
stroke and maximize the potential of balloon angio-
plasty and stenting for the management of stenosis of
the carotid bifurcation.
CONCLUSIONS
Plaques with low echogenicity and those with
stenosis ‡ 90% produced a higher number of embol-
ic particles after ex vivo balloon angioplasty and
stenting. Therefore these lesions may be less suitable
for balloon angioplasty and stenting with currently
used devices. This model can aid in the selection of
appropriate patients and in evaluation of the new
devices and procedures to minimize procedural
complications and maximize the potential for bal-
loon angioplasty and stenting.
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